Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
This study has been completed.
First Received: November 1, 1999   Last Updated: July 23, 2008   History of Changes
Sponsor: National Surgical Adjuvant Breast and Bowel Project (NSABP)
Collaborator: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00003352
  Purpose

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of doxorubicin, cyclophosphamide, and docetaxel in treating women with stage IIIB or stage IV breast cancer.


Condition Intervention Phase
Breast Cancer
Drug: cyclophosphamide
Drug: docetaxel
Drug: doxorubicin hydrochloride
Phase II

Study Type: Interventional
Study Design: Treatment
Official Title: A Phase II Study in Patients With Metastatic or Locally Advanced Breast Cancer to Evaluate the Worth of the Combination of Adriamycin (Doxorubicin), Taxotere (Docetaxel), and Cyclophosphamide (ATC)

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Study Start Date: June 1998
Detailed Description:

OBJECTIVES: I. Determine the overall response rate to doxorubicin, docetaxel, and cyclophosphamide (ATC) in women with metastatic or locally advanced breast cancer. II. Determine survival, time to first response, time to progression, and duration of response in these patients. III. Evaluate the feasibility of administering ATC for at least 4 courses. IV. Evaluate the toxicity profile of ATC and its effect on cardiac function.

OUTLINE: Patients receive intravenous doxorubicin over 15 minutes on day 0, followed by intravenous cyclophosphamide over 30 minutes. An hour after the end of the doxorubicin infusion, intravenous docetaxel is administered over 1 hour. Patients receive courses every 21 days until disease progression or unacceptable toxic effects are observed. When the maximum dose of doxorubicin is reached, treatment continues with docetaxel and cyclophosphamide. Patients with locally advanced breast cancer receive chemotherapy for at least 2 courses after documented response. Patients are followed every 6 weeks.

PROJECTED ACCRUAL: Approximately 89 patients will be accrued to this study within 14 months.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS: Histologically proven metastatic (stage IV) or locally advanced (stage IIIB) adenocarcinoma of the breast Bidimensionally measurable disease No active CNS metastases Brain metastases must be controlled for at least 3 months and have other sites of measurable disease No carcinomatous meningitis No lymphangitic lung metastases as the only site of metastatic disease Hormone receptor status: Any estrogen or progesterone receptor status

PATIENT CHARACTERISTICS: Age: 18 and over Sex: Female Menopausal status: Not specified Performance status: ECOG 0-2 Life expectancy: At least 6 months Hematopoietic: Absolute neutrophil count at least 2,000/mm3 Platelet count at least 100,000/mm3 Hepatic: SGOT and/or SGPT no greater than 2.5 times upper limit of normal (ULN) Alkaline phosphatase no greater than 5 times ULN Bilirubin no greater than ULN No SGOT and/or SGPT greater than 1.5 times ULN if concomitant with alkaline phosphatase greater than 2.5 times ULN Renal: Calcium no greater than 1.2 times ULN Creatinine no greater than 1.5 times ULN Cardiovascular: LVEF at least institutional lower limit of normal on MUGA scan or echocardiogram No myocardial infarction within 6 months No angina pectoris requiring antianginal medication No history of congestive heart failure No cardiac arrhythmias requiring medication No vascular disease with documented cardiac function compromise No uncontrolled hypertension (diastolic greater than 100 mm Hg) Other: Not pregnant or nursing Fertile patients must use effective barrier contraception No diabetics with fasting blood sugar greater than 200 mg/dL No peripheral neuropathy greater than grade 1 No psychosis or addictive disorders No known hypersensitivity to E. coli-derived drugs

PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior chemotherapy for metastatic breast cancer or non-breast cancer At least 12 months since nontaxane containing adjuvant chemotherapy for primary tumor (in patients with metastatic disease) Prior adjuvant chemotherapy with anthracycline containing regimens allowed (provided total doxorubicin dose did not exceed 240 mg/m2) Endocrine therapy: At least 4 weeks since adjuvant hormone or hormone therapy for metastatic disease (at least 2 weeks for rapidly progressive disease) No concurrent hormonal birth control Radiotherapy: At least 4 weeks since prior radiotherapy Prior breast radiotherapy following lumpectomy allowed No radiotherapy to greater than 30% of bone marrow No prior left chest wall radiotherapy with anthracycline containing adjuvant chemotherapy Surgery: Not specified

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00003352

  Hide Study Locations
Locations
United States, Alabama
Baptist Medical Center - Birmingham
Birmingham, Alabama, United States, 35213
Huntsville Hospital System
Huntsville, Alabama, United States, 35801
MBCCOP - University of South Alabama
Mobile, Alabama, United States, 36688
United States, Arizona
CCOP - Greater Phoenix
Phoenix, Arizona, United States, 85006-2726
United States, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205
United States, California
Loma Linda University Medical Center
Loma Linda, California, United States, 92354
CCOP - Bay Area Tumor Institute
Oakland, California, United States, 94609-3305
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California, United States, 95403
Kaiser Permanente Medical Center - Vallejo
Vallejo, California, United States, 94589
Beckman Research Institute, City of Hope
Duarte, California, United States, 91010
Naval Medical Center - Oakland
Oakland, California, United States, 94627-5000
Naval Medical Center - San Diego
San Diego, California, United States, 92134-3202
Saint Mary Medical Center - Long Beach
Long Beach, California, United States, 90813-0887
Scripps Clinic and Research Foundation - La Jolla
La Jolla, California, United States, 92037
Sutter Cancer Center
Sacramento, California, United States, 95816
University of California San Diego Cancer Center
La Jolla, California, United States, 92093-0658
Veterans Affairs Medical Center - San Francisco
San Francisco, California, United States, 94121
Veterans Affairs Satellite Clinic - Sacramento
Sacramento, California, United States, 95820
United States, Colorado
CCOP - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States, 80209-5031
University of Colorado Cancer Center
Denver, Colorado, United States, 80262
United States, Connecticut
Hartford Hospital
Hartford, Connecticut, United States, 06102-5037
United States, Delaware
CCOP - Christiana Care Health Services
Wilmington, Delaware, United States, 19899
United States, Florida
Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida, United States, 32207
CCOP - Mount Sinai Medical Center
Miami Beach, Florida, United States, 33140
MD Anderson Cancer Center Orlando
Orlando, Florida, United States, 32806
Ocala Oncology Center
Ocala, Florida, United States, 34474
Sarasota Memorial Hospital
Sarasota, Florida, United States, 34239
Sylvester Cancer Center, University of Miami
Miami, Florida, United States, 33136
United States, Georgia
CCOP - Atlanta Regional
Atlanta, Georgia, United States, 30342-1701
Medical College of Georgia Comprehensive Cancer Center
Augusta, Georgia, United States, 30912-4000
Veterans Affairs Medical Center - Atlanta (Decatur)
Decatur, Georgia, United States, 30033
Winship Cancer Center
Atlanta, Georgia, United States, 30322
United States, Hawaii
Cancer Research Center of Hawaii
Honolulu, Hawaii, United States, 96813
United States, Illinois
CCOP - Carle Cancer Center
Urbana, Illinois, United States, 61801
CCOP - Central Illinois
Springfield, Illinois, United States, 62526
CCOP - Evanston
Evanston, Illinois, United States, 60201
West Suburban Hospital Medical Center
Oak Park, Illinois, United States, 60302
Illinois Masonic Medical Center
Chicago, Illinois, United States, 60657
Rockford Clinic
Rockford, Illinois, United States, 61103
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, United States, 60612
Highland Park Hospital
Highland Park, Illinois, United States, 60035-2497
United States, Indiana
Community Hospitals of Indianapolis - Regional Cancer Center
Indianapolis, Indiana, United States, 46219
Memorial Hospital of South Bend
South Bend, Indiana, United States, 46601
Methodist Cancer Center - Indianapolis
Indianapolis, Indiana, United States, 46206-1367
United States, Iowa
CCOP - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States, 52403-1206
CCOP - Iowa Oncology Research Association
Des Moines, Iowa, United States, 10309-1016
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242
United States, Kansas
CCOP - Wichita
Wichita, Kansas, United States, 67214-3882
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160-7357
Veterans Affairs Medical Center - Wichita
Wichita, Kansas, United States, 67218
United States, Kentucky
Baptist Hospital East - Louisville
Louisville, Kentucky, United States, 40207
Lucille Parker Markey Cancer Center, University of Kentucky
Lexington, Kentucky, United States, 40536-0093
Norton Healthcare System
Louisville, Kentucky, United States, 40202-5070
United States, Louisiana
CCOP - Ochsner
New Orleans, Louisiana, United States, 70121
Louisiana State University Medical Center - New Orleans
New Orleans, Louisiana, United States, 70112
Tulane University School of Medicine
New Orleans, Louisiana, United States, 70112
Veterans Affairs Medical Center - New Orleans
New Orleans, Louisiana, United States, 70112
United States, Maine
Eastern Maine Medical Center
Bangor, Maine, United States, 04401
United States, Maryland
Franklin Square Hospital Center
Baltimore, Maryland, United States, 21237
National Naval Medical Center
Bethesda, Maryland, United States, 20889-5000
Regional Cancer Therapy Center - Frederick
Frederick, Maryland, United States, 21701
United States, Massachusetts
Baystate Medical Center
Springfield, Massachusetts, United States, 01199
Berkshire Medical Center
Pittsfield, Massachusetts, United States, 01201
Boston Medical Center
Boston, Massachusetts, United States, 02118
Lahey Clinic - Burlington
Burlington, Massachusetts, United States, 01805
New England Medical Center Hospital
Boston, Massachusetts, United States, 02111
United States, Michigan
CCOP - Ann Arbor Regional
Ann Arbor, Michigan, United States, 48106
CCOP - Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States, 49503
CCOP - Kalamazoo
Kalamazoo, Michigan, United States, 49007-3731
Michigan State University
East Lansing, Michigan, United States, 48824
Providence Hospital - Southfield
Southfield, Michigan, United States, 48075-9975
United States, Minnesota
CCOP - Duluth
Duluth, Minnesota, United States, 55805
CCOP - Metro-Minnesota
Saint Louis Park, Minnesota, United States, 55416
Hennepin County Medical Center - Minneapolis
Minneapolis, Minnesota, United States, 55415
United States, Mississippi
Keesler Medical Center - Keesler AFB
Keesler AFB, Mississippi, United States, 39534-2576
United States, Missouri
CCOP - Kansas City
Kansas City, Missouri, United States, 64131
CCOP - St. Louis-Cape Girardeau
Saint Louis, Missouri, United States, 63141
Ellis Fischel Cancer Center - Columbia
Columbia, Missouri, United States, 65203
St. Louis University School of Medicine
Saint Louis, Missouri, United States, 63104
United States, Montana
CCOP - Montana Cancer Consortium
Billings, Montana, United States, 59101
United States, Nebraska
CCOP - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States, 68131
Methodist Cancer Center - Omaha
Omaha, Nebraska, United States, 68114
United States, Nevada
CCOP - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States, 89106
United States, New Jersey
CCOP - Northern New Jersey
Hackensack, New Jersey, United States, 07601
Newark Beth Israel Medical Center
Newark, New Jersey, United States, 07112
Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08903
Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States, 07018-1095
United States, New Mexico
University of New Mexico Cancer Research & Treatment Center
Albuquerque, New Mexico, United States, 87131
United States, New York
Albany Regional Cancer Center
Albany, New York, United States, 12208
State University of New York Health Science Center at Brooklyn
Brooklyn, New York, United States, 11203
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
Syracuse, New York, United States, 13210
Genesee Hospital - Rochester
Rochester, New York, United States, 14607
Mount Sinai Medical Center, NY
New York, New York, United States, 10029
CCOP - North Shore University Hospital
Manhasset, New York, United States, 11030
Staten Island University Hospital
Staten Island, New York, United States, 10305
United States, North Carolina
CCOP - Southeast Cancer Control Consortium
Winston-Salem, North Carolina, United States, 27104-4241
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157-1082
East Carolina University School of Medicine
Greenville, North Carolina, United States, 27858-4354
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, United States, 27599-7295
United States, North Dakota
CCOP - Merit Care Hospital
Fargo, North Dakota, United States, 58122
Veterans Affairs Medical Center - Fargo
Fargo, North Dakota, United States, 58102
United States, Ohio
Akron City Hospital
Akron, Ohio, United States, 44309
Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States, 43210
Barrett Cancer Center, The University Hospital
Cincinnati, Ohio, United States, 45219
CCOP - Columbus
Columbus, Ohio, United States, 43206
CCOP - Dayton
Kettering, Ohio, United States, 45429
CCOP - Toledo Community Hospital Oncology Program
Toledo, Ohio, United States, 43623-3456
Good Samaritan Hospital - Cincinnati
Cincinnati, Ohio, United States, 45220
Jewish Hospital of Cincinnati, Inc.
Cincinnati, Ohio, United States, 45236
Meridia South Pointe Hospital
Cleveland, Ohio, United States, 44122
Mount Sinai Medical Center - Cleveland
Cleveland, Ohio, United States, 44122
Veterans Affairs Medical Center - Dayton
Dayton, Ohio, United States, 45428
United States, Oklahoma
CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center
Tulsa, Oklahoma, United States, 74136
United States, Oregon
CCOP - Columbia River Program
Portland, Oregon, United States, 97213
Oregon Cancer Center at Oregon Health Sciences University
Portland, Oregon, United States, 97201-3098
United States, Pennsylvania
Albert Einstein Cancer Center
Philadelphia, Pennsylvania, United States, 19141
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15212-4772
CCOP - MainLine Health
Wynnewood, Pennsylvania, United States, 19096
Lehigh Valley Hospital
Allentown, Pennsylvania, United States, 18105-1556
Penn State Geisinger Medical Center
Danville, Pennsylvania, United States, 17822-2001
Reading Hospital and Medical Center
Reading, Pennsylvania, United States, 19612-6052
St. Luke's Network - Bethlehem
Bethlehem, Pennsylvania, United States, 18015
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States, 15213
Veterans Affairs Medical Center - Pittsburgh
Pittsburgh, Pennsylvania, United States, 15240
United States, Rhode Island
Kent County Memorial Hospital - Rhode Island
Warwick, Rhode Island, United States, 02886
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
United States, South Carolina
CCOP - Greenville
Greenville, South Carolina, United States, 29615
CCOP - Upstate Carolina
Spartanburg, South Carolina, United States, 29303
Medical University of South Carolina
Charleston, South Carolina, United States, 29425-0721
United States, South Dakota
CCOP - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States, 57105-1080
United States, Tennessee
CCOP - Baptist Cancer Institute
Memphis, Tennessee, United States, 38117
Veterans Affairs Medical Center - Memphis
Memphis, Tennessee, United States, 38104
United States, Texas
Kelsey Seybold Clinic
Houston, Texas, United States, 77025
MBCCOP - South Texas Pediatric
San Antonio, Texas, United States, 78284-7810
Medical Group of Texas
Dallas, Texas, United States, 75243
University of Texas Health Center at Tyler
Tyler, Texas, United States, 75710
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78284
Wilford Hall - 59th Medical Wing
Lackland Air Force Base, Texas, United States, 78236-5300
United States, Utah
Utah Valley Regional Medical Center - Provo
Provo, Utah, United States, 84604
United States, Virginia
Eastern Virginia Medical School
Norfolk, Virginia, United States, 23507
Massey Cancer Center
Richmond, Virginia, United States, 23298-0037
Virginia Oncology Associates
Newport News, Virginia, United States, 23606
Oncology and Hematology Associates of Southwest Virginia, Inc.
Roanoke, Virginia, United States, 24014
Veterans Affairs Medical Center - Richmond
Richmond, Virginia, United States, 23249
Veterans Affairs Medical Center - Salem
Salem, Virginia, United States, 24153
MBCCOP - Massey Cancer Center
Richmond, Virginia, United States, 23298-0037
United States, Washington
CCOP - Northwest
Tacoma, Washington, United States, 98405-0986
CCOP - Virginia Mason Research Center
Seattle, Washington, United States, 98101
Puget Sound Oncology Consortium
Seattle, Washington, United States, 98109
United States, West Virginia
Camden-Clark Memorial Hospital
Parkersburg, West Virginia, United States, 26102
United States, Wisconsin
CCOP - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, United States, 54449
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada, T2N 4N2
Canada, British Columbia
British Columbia Cancer Agency
Vancouver, British Columbia, Canada, V5Z 4E6
Canada, Manitoba
Manitoba Cancer Treatment and Research Foundation
Winnipeg, Manitoba, Canada, R3E 0V9
Canada, Ontario
St. Michael's Hospital - Toronto
Toronto, Ontario, Canada, M5B 1W8
Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada, M4N 3M5
Canada, Quebec
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada, H2W-W1T8
Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec
Quebec City, Quebec, Canada, G1R 2J6
Hopital Laval
Ste-Foy, Quebec, Canada, G1V 4G5
Jewish General Hospital - Montreal
Montreal, Quebec, Canada, H3T 1E2
Montreal General Hospital
Montreal, Quebec, Canada, H3G 1A4
Royal Victoria Hospital - Montreal
Montreal, Quebec, Canada, H3A 1A1
Puerto Rico
MBCCOP - San Juan
San Juan, Puerto Rico, 00927-5800
Veterans Affairs Medical Center - San Juan
San Juan, Puerto Rico, 00927-5800
Sponsors and Collaborators
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Investigators
Study Chair: Terry Mamounas, MD, MPH, FACS Aultman Cancer Center at Aultman Hospital
  More Information

Additional Information:
Publications:
Study ID Numbers: CDR0000066333, NSABP-BP-58
Study First Received: November 1, 1999
Last Updated: July 23, 2008
ClinicalTrials.gov Identifier: NCT00003352     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
stage IV breast cancer
recurrent breast cancer
stage IIIB breast cancer

Additional relevant MeSH terms:
Molecular Mechanisms of Pharmacological Action
Skin Diseases
Immunologic Factors
Antineoplastic Agents
Physiological Effects of Drugs
Breast Neoplasms
Cyclophosphamide
Antibiotics, Antineoplastic
Immunosuppressive Agents
Doxorubicin
Pharmacologic Actions
Docetaxel
Neoplasms
Neoplasms by Site
Therapeutic Uses
Myeloablative Agonists
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Alkylating Agents
Breast Diseases

ClinicalTrials.gov processed this record on November 27, 2009